Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients-Reference-Cited by-同舟云学术

Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients

Published:2021-02-06 Issue: Volume: Page:
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Frol Senta^ORCID,Sernec Lana Podnar,Hudnik Liam Korošec,Šabovič Mišo,Oblak Janja Pretnar

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

http://link.springer.com/content/pdf/10.1007/s40263-021-00792-2.pdf

Reference32 articles.

1. Kermer P, Eschemfelder C, Diener HC, et al. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany: updated series of 120 cases. Int J Stroke. 2020;15(6):709–18. https://doi.org/10.1177/1747493019895654.

2. Pollack CV Jr, Reilly PA, van Ryn J, et al. Idarucizumab for dabigatran reversal-full cohort analysis. N Engl J Med. 2015;373:431–41.

3. Thibault N, Morril AM, Wilett KC. Idarucizumab for reversing dabigatran-induced anticoagulation: a systematic review. Am J Ther. 2018;25:e333–8.

4. Steffel J, Verhame P, Potpara T, et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39:1330–93.

5. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–51.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke;Neurology;2024-10-08

2. Reversing dabigatran effect with idarucizumab to enable intravenous thrombolysis in patients with acute ischaemic stroke — a single centre experience;Neurologia i Neurochirurgia Polska;2023-12-29

3. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta‐Analysis;Journal of the American Heart Association;2023-12-19

4. Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes;Thrombosis Research;2023-08

5. Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke;Journal of Thrombosis and Thrombolysis;2023-02-04